259 related articles for article (PubMed ID: 21841504)
1. Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens.
Sigel CS; Moreira AL; Travis WD; Zakowski MF; Thornton RH; Riely GJ; Rekhtman N
J Thorac Oncol; 2011 Nov; 6(11):1849-56. PubMed ID: 21841504
[TBL] [Abstract][Full Text] [Related]
2. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
[TBL] [Abstract][Full Text] [Related]
3. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.
Rekhtman N; Brandt SM; Sigel CS; Friedlander MA; Riely GJ; Travis WD; Zakowski MF; Moreira AL
J Thorac Oncol; 2011 Mar; 6(3):451-8. PubMed ID: 21266922
[TBL] [Abstract][Full Text] [Related]
4. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic concordance of non-small cell lung carcinoma subtypes between biopsy and cytology specimens obtained during the same procedure.
Ebrahimi M; Auger M; Jung S; Fraser RS
Cancer Cytopathol; 2016 Oct; 124(10):737-743. PubMed ID: 27172103
[TBL] [Abstract][Full Text] [Related]
6. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.
Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini EM; Guazzi A; Ardizzoni A
J Thorac Oncol; 2011 Mar; 6(3):489-93. PubMed ID: 21258246
[TBL] [Abstract][Full Text] [Related]
8. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S
Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of cytology in sub typing non small cell lung carcinomas.
Patel TS; Shah MG; Gandhi JS; Patel P
Diagn Cytopathol; 2017 Jul; 45(7):598-603. PubMed ID: 28429425
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of fine needle aspiration cytology and core biopsy histopathology with or without immunohistochemical staining in the subtyping of the non-small cell lung carcinomas: Experience from an academic centre in Turkey.
Bayrak BY; Paksoy N; Vural Ç
Cytopathology; 2021 May; 32(3):331-337. PubMed ID: 33145811
[TBL] [Abstract][Full Text] [Related]
11. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.
Warth A; Muley T; Herpel E; Meister M; Herth FJ; Schirmacher P; Weichert W; Hoffmann H; Schnabel PA
Histopathology; 2012 Dec; 61(6):1017-25. PubMed ID: 22882703
[TBL] [Abstract][Full Text] [Related]
12. Subtyping of nonsmall cell lung cancer on cytology specimens: reproducibility of cytopathologic diagnoses on sparse material.
Omland SH; Henrik H; Olsen EK; Birthe T; Guldhammer SB
Diagn Cytopathol; 2014 Feb; 42(2):105-10. PubMed ID: 23687077
[TBL] [Abstract][Full Text] [Related]
13. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
Noh S; Shim H
Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
[TBL] [Abstract][Full Text] [Related]
14. Are EUS-FNA and EBUS-TBNA specimens reliable for subtyping non-small cell lung cancer?
Tournoy KG; Carprieaux M; Deschepper E; van Meerbeeck JP; Praet M
Lung Cancer; 2012 Apr; 76(1):46-50. PubMed ID: 21945658
[TBL] [Abstract][Full Text] [Related]
15. The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non-small cell lung cancer: An institutional experience.
Sekar A; Gupta N; Rajwanshi A; Chaturvedi R; Singh N; Lal A
Cytopathology; 2017 Oct; 28(5):371-377. PubMed ID: 28730709
[TBL] [Abstract][Full Text] [Related]
16. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.
Heymann JJ; Bulman WA; Swinarski D; Pagan CA; Crapanzano JP; Haghighi M; Fazlollahi L; Stoopler MB; Sonett JR; Sacher AG; Shu CA; Rizvi NA; Saqi A
Cancer Cytopathol; 2017 Dec; 125(12):896-907. PubMed ID: 29024471
[TBL] [Abstract][Full Text] [Related]
18. Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.
Kriegsmann M; Casadonte R; Kriegsmann J; Dienemann H; Schirmacher P; Hendrik Kobarg J; Schwamborn K; Stenzinger A; Warth A; Weichert W
Mol Cell Proteomics; 2016 Oct; 15(10):3081-3089. PubMed ID: 27473201
[TBL] [Abstract][Full Text] [Related]
19. Performance of Ventana SP263 PD-L1 assay in endobronchial ultrasound guided-fine-needle aspiration derived non-small-cell lung carcinoma samples.
Chauhan A; Siegel L; Freese R; Racila E; Stewart J; Amin K
Diagn Cytopathol; 2021 Mar; 49(3):355-362. PubMed ID: 33142053
[TBL] [Abstract][Full Text] [Related]
20. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
